| Ytd | -48.70% | |
| 1y | -50.57% |
| Open | 0.77 | Prev Close | 0.80 | Low | 0.77 | High | 0.87 | Mkt Cap | 3.81M |
| Vol | 13.43K | Avg Vol | 259.14K | EPS | -0.17 | P/E | N/A | Forward P/E | N/A |
| Beta | 0.09 | Short Ratio | 2.65 | Inst. Own | 4.16% | Dividend | 0.20 | Div Yield | 10.53 |
| Ex Div Date | 12-12 | Earning | 07-14 | 50-d Avg | 0.79 | 200-d Avg | 1.09 | 1yr Est | 0.00 |
Allison Holdings (ALSN) offers a compelling buying opportunity, trading at a ~43% P/E discount to pe
GSK to acquire Nuvalent for $10.6 billion, shares rise 38.2%. Other gainers include CCTG, CHAI, RGNT